Palantir stock is back near all-time highs ahead of its Q4 report, along with Amazon.com and Google parent Alphabet.
AbbVie stock retook its 200-day moving average Friday after the company raised its long-term outlook for Skyrizi and Rinvoq by $4 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback